Lista de obras - Leilei Chen - Dominio Público Uruguay

A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma

artículo científico publicado en 2014

ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.

artículo científico publicado en 2016

ADAR1: a promising new biomarker for esophageal squamous cell carcinoma?

artículo científico publicado en 2014

AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways.

artículo científico publicado en 2016

AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer

artículo científico publicado en 2018

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

scientific article published on 30 July 2018

Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma

artículo científico publicado en 2013

An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer

artículo científico publicado en 2017

ApoA-1 accelerates regeneration of small-for-size fatty liver graft after transplantation

artículo científico publicado en 2018

Author Correction: Systematic evaluation and optimization of the experimental steps in RNA G-quadruplex structure sequencing

artículo científico publicado en 2020

Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer

scientific article published on 01 September 2018

CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer

scientific article published on 14 August 2019

CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.

artículo científico publicado en 2010

CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.

artículo científico publicado en 2016

Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.

artículo científico publicado en 2013

Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.

artículo científico

Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.

artículo científico publicado en 2010

Chemically-Induced Cancers Do Not Originate from Bone Marrow-Derived Cells ⬇️

artículo científico publicado el 24 de enero de 2012

Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.

artículo científico publicado en 2009

Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.

artículo científico publicado en 2010

Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development

artículo científico publicado en 2020

Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.

artículo científico publicado en 2010

Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma.

artículo científico publicado en 2010

Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.

artículo científico publicado en 2013

Establishment and characterization of human non-small cell lung cancer cell lines

artículo científico publicado en 2011

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer

artículo científico publicado en 2018

Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.

artículo científico publicado en 2011

Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression

artículo científico publicado en 2012

Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells

artículo científico publicado en 2015

MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor ⬇️

artículo científico publicado el 3 de agosto de 2011

Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer

artículo científico publicado en 2022

Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.

artículo científico publicado en 2011

Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility.

artículo científico publicado en 2015

Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma

artículo científico publicado en 2011

Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.

artículo científico publicado en 2010

RNA editome imbalance in hepatocellular carcinoma.

artículo científico

Regulatory factors governing adenosine-to-inosine (A-to-I) RNA editing

artículo científico publicado en 2015

Role of translationally controlled tumor protein in cancer progression.

artículo científico publicado en 2012

SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma.

artículo científico publicado en 2012

SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.

artículo científico publicado en 2012

Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma.

artículo científico publicado en 2012

Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression

artículo científico publicado en 2020

Systematic evaluation and optimization of the experimental steps in RNA G-quadruplex structure sequencing

scientific article published on 30 May 2019

Transgenic CHD1L expression in mouse induces spontaneous tumors

artículo científico publicado en 2009

Lista de obras de Leilei Chen

A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma

ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.

ADAR1: a promising new biomarker for esophageal squamous cell carcinoma?

AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways.

AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma

An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer

ApoA-1 accelerates regeneration of small-for-size fatty liver graft after transplantation

Author Correction: Systematic evaluation and optimization of the experimental steps in RNA G-quadruplex structure sequencing

Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer

CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer

CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.

CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.

Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.

Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.

Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.

Chemically-Induced Cancers Do Not Originate from Bone Marrow-Derived Cells ⬇️

Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.

Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.

Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development

Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.

Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma.

Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.

Establishment and characterization of human non-small cell lung cancer cell lines

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer

Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.

Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression

Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells

MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor ⬇️

Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer

Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.

Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility.

Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma

Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.

RNA editome imbalance in hepatocellular carcinoma.

Regulatory factors governing adenosine-to-inosine (A-to-I) RNA editing

Role of translationally controlled tumor protein in cancer progression.

SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma.

SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.

Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma.

Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression

Systematic evaluation and optimization of the experimental steps in RNA G-quadruplex structure sequencing

Transgenic CHD1L expression in mouse induces spontaneous tumors